Brief: Celltrion Wins Sales Approval Recommendation For Its CT-P16 From European Medicines Agency's Committee
27/06/2022 24:34
June 27 (Reuters) - Celltrion Inc 068270.KS :
* WINS SALES APPROVAL RECOMMENDATION FOR ITS CT-P16 FROM
EUROPEAN
MEDICINES AGENCY'S COMMITTEE
Further company coverage: 068270.KS
(Reporting by ByungwookKim Kim)
((Byungwook.Kim@thomsonreuters.com;))
Recent news on Celltrion
See all newsBrief: Celltrion Inc To Acquire 100 Billion Won Worth Of Own Shares
Brief: Celltrion Q1 Operating. Profit 322 Billion Won, Up 115% Y/Y
Brief: Celltrion To Cancel 100 Billion Won Treasury Shares
Brief: Celltrion Plans Phase 3 Clinical Trials For Keytruda Biosimilar With 220 Patients
Brief: Celltrion To Buy 100 Billion Won Of Own Shares